Cervical Cancer
Cervical cancer is mainly associated with persistent infection by high-risk HPV types. When detected early it can be treated effectively — regular gynecological check-ups, HPV testing, Pap smears and prompt investigation of symptoms are therefore crucial.
Symptoms of cervical cancer
In early stages, cervical cancer often causes no symptoms. This is why screening remains essential even when a woman feels well or has been vaccinated against HPV.
- Bleeding after sexual intercourse, between periods or after menopause.
- Watery, foul-smelling or bloody vaginal discharge that persists or changes in volume and color.
- Pain in the pelvis, lower back or discomfort unrelated to the menstrual period.
- Pain or bleeding during sexual intercourse.
- Pelvic heaviness, fatigue, weight loss or reduced appetite in more advanced disease.
- Swelling in the legs, difficulty urinating or pain radiating to the legs in locally advanced disease.
When urgent gynecological assessment is needed
Any unusual vaginal bleeding needs evaluation, especially after intercourse or after menopause. Symptoms do not always mean cancer, but they should not be automatically attributed to hormonal changes, infection or stress without examination.
- Bleeding after intercourse, even if minimal.
- New bleeding after menopause.
- Recurrent vaginal discharge with odor or blood.
- Abnormal Pap smear or positive high-risk HPV test.
- History of CIN precancerous lesions, previous cone biopsy or immunosuppression.
Risk factors and the role of HPV
Persistent high-risk HPV infection is the main factor for developing precancerous lesions and cervical cancer. Lesions usually progress slowly over years, providing valuable time for prevention and treatment before they become invasive.
- Irregular gynecological check-ups or delays after an abnormal Pap smear.
- Persistent high-risk HPV infection, especially types 16 and 18.
- Smoking, which increases the risk of HPV persistence and progression.
- Immunosuppression, HIV infection or chronic use of immunosuppressive medications.
- Previous history of CIN2, CIN3 or treatment of precancerous lesions.
Diagnosis of cervical cancer
Diagnosis starts with a clinical gynecological examination and is confirmed by histology. The Pap smear and HPV test are screening tests — when a suspicious finding is present, colposcopy and biopsy determine the nature of the lesion precisely.
- HPV test: Detects high-risk HPV types associated with precancerous lesions and cervical cancer.
- Pap smear: Examines cervical cells for abnormalities, inflammation, dysplasia or suspicious cancer cells.
- Clinical gynecological examination: Assessment of cervix, vagina, uterus and pelvis based on symptoms and history.
- Colposcopy: Magnified examination of the cervix after applying special solutions to identify suspicious areas.
- Cervical biopsy: A small tissue sample is taken for histological examination, essential for definitive diagnosis.
- Cone biopsy: Diagnostic and therapeutic removal of a cervical cone when more precise evaluation or treatment of high-grade lesions is needed.
What an abnormal Pap smear or positive HPV test means
An abnormal Pap smear or a positive HPV test does not necessarily mean cancer. It means that organized investigation is needed to distinguish a transient HPV infection from a precancerous lesion requiring treatment.
- ASC-US or LSIL often require follow-up, HPV typing or colposcopy depending on age and history.
- HSIL, ASC-H or suspicious cytological findings need immediate colposcopic evaluation.
- CIN1 is usually monitored, while CIN2/CIN3 often requires ablative treatment.
- The final decision is based on a combination of age, history, HPV type, colposcopy and biopsy.
Staging and imaging
If invasive cancer is confirmed, the next step is staging. Staging shows how far the disease extends and determines whether the best approach is surgical, radiotherapy, chemotherapy or combined.
- Pelvic MRI to assess tumor size, local extension and relation to parametria, vagina and adjacent organs.
- CT scan or PET/CT when lymph node or distant disease assessment is needed.
- Laboratory workup and preoperative evaluation, tailored to the stage and the patient's overall profile.
- Discussion in a multidisciplinary tumor board, especially when a combination of surgery, radiotherapy and systemic therapy is required.
Treatment of cervical cancer
Cervical cancer treatment is individualized based on stage, lesion size, age, general health and desire for fertility preservation. The goal is oncologically safe management with the least possible burden for the patient.
- Precancerous lesions: Monitoring, LEEP/LETZ or cone biopsy when high-grade lesions are present.
- Very early disease: Cone biopsy or trachelectomy in selected patients who wish to preserve fertility.
- Early invasive cancer: Surgical treatment with radical hysterectomy and lymph node assessment when appropriate criteria are met.
- Sentinel lymph node: In selected cases, ICG mapping can be used for more precise lymph node evaluation with less morbidity.
- Locally advanced disease: Combined chemoradiotherapy, often with brachytherapy, according to stage and international oncological guidelines.
- Recurrent or metastatic disease: Systemic therapies, immunotherapy or targeted options where indicated, always after specialized oncological evaluation.
Follow-up after treatment
Completing treatment does not mean care stops. Regular follow-up helps detect recurrence early, manage side effects and ensure the woman's safe return to her life.
- Scheduled visits with gynecological examination and symptom assessment.
- Cytological, HPV or imaging follow-up when indicated by history or findings.
- Immediate contact with the doctor for new bleeding, pain, persistent discharge or unexplained weight loss.
- Coordinated care with an oncologist, radiotherapist, physiotherapist or psychologist where needed.
Fertility preservation and quality of life
In younger women, the possibility of fertility preservation is discussed from the start. It is not suitable for every stage, but in very early forms there may be options that protect the uterus without compromising oncological safety.
- Assessment of stage, tumor size and lymph node risk before any decision.
- Discussion of trachelectomy or conservative surgery only when strict criteria are met.
- Information about possible effects on pregnancy, such as increased risk of preterm birth after cervical procedures.
- Support for sexual health, menopause, lymphedema, psychological burden and return to daily life.
Symptoms
In early stages, cervical cancer often causes no symptoms. This is why screening remains essential even when a woman feels well or has been vaccinated against HPV.
- Bleeding after sexual intercourse, between periods or after menopause.
- Watery, foul-smelling or bloody vaginal discharge that persists or changes in volume and color.
- Pain in the pelvis, lower back or discomfort unrelated to the menstrual period.
- Pain or bleeding during sexual intercourse.
- Pelvic heaviness, fatigue, weight loss or reduced appetite in more advanced disease.
- Swelling in the legs, difficulty urinating or pain radiating to the legs in locally advanced disease.
Any unusual vaginal bleeding needs evaluation, especially after intercourse or after menopause. Symptoms do not always mean cancer, but they should not be automatically attributed to hormonal changes, infection or stress without examination.
- Bleeding after intercourse, even if minimal.
- New bleeding after menopause.
- Recurrent vaginal discharge with odor or blood.
- Abnormal Pap smear or positive high-risk HPV test.
- History of CIN precancerous lesions, previous cone biopsy or immunosuppression.
Persistent high-risk HPV infection is the main factor for developing precancerous lesions and cervical cancer. Lesions usually progress slowly over years, providing valuable time for prevention and treatment before they become invasive.
- Irregular gynecological check-ups or delays after an abnormal Pap smear.
- Persistent high-risk HPV infection, especially types 16 and 18.
- Smoking, which increases the risk of HPV persistence and progression.
- Immunosuppression, HIV infection or chronic use of immunosuppressive medications.
- Previous history of CIN2, CIN3 or treatment of precancerous lesions.
This information is for educational purposes and does not replace medical advice. For diagnosis and personalized treatment, book an appointment.
Need an assessment?
Book an appointment at the Athens or Ioannina offices for a personalized evaluation with the doctor.